GRIFOLS | GRF - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Alcon AG USD 2.41B 4M 2026-03
Almirall EUR 517.4M 32K 2025-12
Amadeus IT EUR 1.19B 91.3M 2026-03
Amarin USD 51.48M 113K 2025-12
argenx SE USD 904M 10.57M 2026-03
AstraZeneca USD 8.18B 4.35B 2026-03
Bayer EUR 9.88B 452M 2026-03
Cie Automotive EUR 1.69B 20.74M 2025-12
Demant DKK 9.63B 241M 2025-12
Ence Energia y Celulosa EUR 224.43M 29.03M 2025-12
Essilor EUR 13.09B 1.07B 2025-12
Ferrovial EUR 4.62B 584M 2025-12
Fresenius EUR 5.25B 337M 2025-12
Fresenius Medical Care EUR 4.34B 63M 2026-03
Genmab DKK 798M 235M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
GRIFOLS EUR 1.45B 255.28M 2026-03
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Inditex EUR 6.99B 2.64B 2026-03
Lakefront Biotherapeutics EUR 70.18M 50.08M 2026-03
Merck EUR 4.09B 687M 2026-03
Novartis USD 9.29B 507M 2026-03
Philips EUR 3.6B 775M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
Smith & Nephew USD 2.52B 84M 2025-12
UCB EUR 2.96B 196M 2025-12
Viscofan EUR 262.6M 2.21M 2026-03